TriSalus Life Sciences (TLSI) Gross Profit (2022 - 2025)
Historic Gross Profit for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $9.7 million.
- TriSalus Life Sciences' Gross Profit rose 5224.59% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.8 million, marking a year-over-year increase of 4425.75%. This contributed to the annual value of $25.3 million for FY2024, which is 5923.55% up from last year.
- Per TriSalus Life Sciences' latest filing, its Gross Profit stood at $9.7 million for Q3 2025, which was up 5224.59% from $9.4 million recorded in Q2 2025.
- In the past 5 years, TriSalus Life Sciences' Gross Profit registered a high of $9.7 million during Q3 2025, and its lowest value of $2.3 million during Q1 2023.
- For the 4-year period, TriSalus Life Sciences' Gross Profit averaged around $5.7 million, with its median value being $5.5 million (2024).
- Over the last 5 years, TriSalus Life Sciences' Gross Profit had its largest YoY gain of 13626.18% in 2024, and its largest YoY loss of 3708.89% in 2024.
- TriSalus Life Sciences' Gross Profit (Quarter) stood at $2.4 million in 2022, then soared by 113.24% to $5.1 million in 2023, then surged by 37.09% to $7.0 million in 2024, then surged by 37.12% to $9.7 million in 2025.
- Its last three reported values are $9.7 million in Q3 2025, $9.4 million for Q2 2025, and $7.7 million during Q1 2025.